Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lloyd

Showing results (451-460 of 486) with videos related to

Pageof 49
Sort By:
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Ophthalmology|March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year ResultsCarl Regillo, Brian Berger, Logan Brooks, et al.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Journal of Analytical Toxicology|July 17, 2020
Endogenous GHB in Segmented Hair Part I: Inter-individual Variation for Group ComparisonsJennifer L Thomas, Erin C Strickland, Erin W Lloyd, et al.
The Laryngoscope|February 27, 2025
Quality of Life Outcomes in Vestibular Schwannoma: A Prospective Analysis of Treatment ModalitiesA Hotchkies, E Heward, A Wadeson, et al.
The Laryngoscope|February 9, 2024
Improved Recovery after Vestibular Schwannoma Excision with Intratympanic Gentamicin PrehabilitationMathieu Trudel, Emma J Stapleton, Andrea M Wadeson, et al.
JAMA Ophthalmology|August 3, 2023
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical TrialCharles C Wykoff, David M Brown, Kimberly Reed, et al.
JAMA Ophthalmology|August 5, 2021
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical TrialDavid M Brown, Charles C Wykoff, David Boyer, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 10, 2022
Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repairTrevor Simard, Yogesh N V Reddy, Jeremy J Thaden, et al.
Biomaterials|June 22, 2005
Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsisSusan R Sandeman, Carol A Howell, Gary J Phillips, et al.
Pageof 49

Showing results (451-460 of 486) with videos related to

Sort By:
Pageof 49
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Ophthalmology|March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year ResultsCarl Regillo, Brian Berger, Logan Brooks, et al.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Journal of Analytical Toxicology|July 17, 2020
Endogenous GHB in Segmented Hair Part I: Inter-individual Variation for Group ComparisonsJennifer L Thomas, Erin C Strickland, Erin W Lloyd, et al.
The Laryngoscope|February 27, 2025
Quality of Life Outcomes in Vestibular Schwannoma: A Prospective Analysis of Treatment ModalitiesA Hotchkies, E Heward, A Wadeson, et al.
The Laryngoscope|February 9, 2024
Improved Recovery after Vestibular Schwannoma Excision with Intratympanic Gentamicin PrehabilitationMathieu Trudel, Emma J Stapleton, Andrea M Wadeson, et al.
JAMA Ophthalmology|August 3, 2023
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical TrialCharles C Wykoff, David M Brown, Kimberly Reed, et al.
JAMA Ophthalmology|August 5, 2021
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical TrialDavid M Brown, Charles C Wykoff, David Boyer, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 10, 2022
Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repairTrevor Simard, Yogesh N V Reddy, Jeremy J Thaden, et al.
Biomaterials|June 22, 2005
Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsisSusan R Sandeman, Carol A Howell, Gary J Phillips, et al.
Pageof 49